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The rapid growth of aquaculture has provided opportunities
for the emergence of diseases. Programs designed to monitor
these pathogens are useful for analysis of regional variation and
trends, provided methods are standardized. Data from an offi-
cial monitoring program were used to analyze the emergence of
infectious pancreatic necrosis virus in Scottish salmon farms
from 1996 to 2001. An annual increase in the prevalence of this
virus was found in saltwater (10%) and freshwater sites (2% to
3%), with a much faster increase (6.5%) in Shetland’s freshwa-
ter sites. No significant increase in the virus was detected in the
marine farms of southern mainland Scotland. However, the
virus had become very prevalent at marine sites and was
almost ubiquitous in Shetland by 2001. The prevalence of this
virus at marine sites may be underestimated. Because several
diseases have emerged or are emerging in fish farming, aqua-
culture surveillance programs represent a rich potential source
of data on emerging diseases.
T
he growth of the aquaculture industry provides a rich envi-
ronment in which to study emergence of pathogens (1,2).
New fish species are being cultivated, and production has risen
rapidly. For example, from 1996 to 2001, Scottish farmed
salmon production doubled to 158,000 metric tons (3).
Shipping is extensive, and stock movement between farms is
substantial (4). Thus, both host populations and contact oppor-
tunities are high, the ideal theoretical conditions for disease
transmission (5). Indeed, an array of pathogens that affect
farmed salmon have emerged (6).
Because of the disease threat, official (6,7) and industry (8)
surveillance for pathogens is extensive. This surveillance is
designed to find pathogens, and thus may bias estimates of true
pathogen prevalence. Sampling may be biased to farms per-
ceived to be at risk or to specific times of year. The number of
fish in a sample may vary. Similarly, sampling methods have
detection limits, which may result in substantial numbers of
asymptomatic infections being undetected (9,10).
Nevertheless, a continuous centrally organized national survey
exists for pathogens in an environment where pathogens are
emerging. This survey has the potential to throw detailed light
on patterns of pathogen emergence, even if absolute prevalence
may be biased.
Infectious pancreatic necrosis (IPN) is considered the most
serious viral disease in terms of its impact on Atlantic salmon
(Salmo salar) production in the European Union (11); the dis-
ease occurs on four continents (7). The problem is increasing as
the disease continues to emerge (12). IPN is caused by the
Infectious pancreatic necrosis virus (IPNV; genus
Aquabirnavirus) (13,14). Presence of IPNV is a necessary, but
not sufficient, condition for IPN; disease also depends upon
viral strain (15), environment (12), and age of the fish (12,13).
In nondiseased fish, IPNV may be present in small quantities
(13,16); virus in such carrier fish may be difficult to detect,
which leads to underreporting (9,10). 
IPN has been known for decades. It was first described in
North America in freshwater trout in the 1950s (17), although
indications of the disease were reported in 1940 (16). IPN was
first reported in the United Kingdom in 1971 (18) in rainbow
trout, Oncorhynchus mykiss, a North American species. Early
reports of IPN in salmonids were associated with deaths of fry
(recently hatched fishes) in freshwater hatcheries (13), but
since the 1980s, deaths have also been increasingly reported
among smolts (2-year-old salmon) shortly after transfer to sea-
water (15,12). IPNV-positive salmon smolts are estimated to
have a mortality rate five times higher than IPNV-negative
smolts (14). IPN is also associated with less easily quantified
losses such as loss of appetite and therefore of production (19).
Methods
Fisheries Research Services (FRS) fisheries inspectors have
sampled fish from throughout Scotland for pathogens, includ-
ing IPNV, for many years. The inspectorate is based in
Aberdeen (Figure 1), distant from salmon farming areas on the
west coast and Northern Isles (3). This central organization is
important for the sampling structure because the same persons
collected samples from different regions using standard operat-
ing procedures, and a single laboratory then processed these
samples.
The IPNV diagnosis used cell culture on Chinook salmon
embryo cell lines in plates containing 24 wells (7). Virus iden-
tification was undertaken with enzyme-linked immunosorbent
assay (7). The standard sample from 30 fish was divided into
six pools, each containing material from five kidneys; occa-
sionally 30 pools from individual kidneys were sampled.
However, some samples did not contain 30 fish, depending
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size also varied. Any positive pool generated a positive result at
the sample level. Because samples with smaller numbers of fish
are less likely to contain virus than are large ones (20), IPNV
may be missed in small samples. In addition, limits of test sen-
sitivity mean that fish with low IPNV titers may escape detec-
tion (9,10), although if samples are large enough to contain sev-
eral infected fish, test sensitivity is likely to be less important
in detecting IPNV at the sample level (20). Small samples from
biased locations and test detection limits mean that errors may
exist in the absolute prevalence estimates, but with standard
methods and centralized personnel, trends and relative region-
al prevalence can be determined. 
FRS scientists have been testing for IPNV since the 1970s
(18); standard methods approved by the Office International
des Epizooties (7) were used through the 1990s. In freshwater,
sonication has been applied to tissue homogenate since 1993 to
disrupt cells and release virus; in saltwater, this process was not
begun until 2001. Thus, sensitivity of detection may have been
slightly improved for marine samples in the last year and was
generally better in freshwater.
Data available for 1996–2001 have been used to find under-
lying patterns in the distribution of prevalence of IPNV in
Scottish salmon farms. Fish were sampled at all stages of the
production cycle, although many more samples were collected
in summer than in winter, leading to potential biases. Also,
inspectors preferentially take moribund fish because these are
of most concern and could indicate a disease outbreak. Most
sites were only sampled at most once in a given year, but a
minority (8.5% in 1996, 12.3% in 1997, 7.9% in 1998, 15% in
1999, 26% in 2000, and 31% in 2001) were sampled on two or
more occasions in a single year. All farms are sampled at least
once every 2 years. Data are insufficient to systematically ana-
lyze variation at sites.
The mean prevalence of IPNV was calculated for classes of
samples, e.g., marine salmon farms in Shetland in 1996.
(Prevalence was the proportion of samples that were IPNV pos-
itive for the class of site examined.) The use of prevalence
removed the bias associated with different sampling frequen-
cies. Confidence intervals were determined from the probabili-
ty values for which distribution intercepts with observations,
for the number of observations available. For a more formal
test of when regional means deviated significantly from the
overall mean, we used the χ
2 test, because the data were bino-
mially distributed. Site samples were not fully independent, but
most sites were not sampled more than once in a year and thus
were semi-independent. Clumping of samples could also have
occurred for sites within hydrodynamically well-mixed envi-
ronments (e.g., farms in the same sea loch). 
Regional patterns exist for IPN; Shetland has a particularly
serious problem (16). Regional variation in IPN-induced deaths
is also apparent in Norway (12). Regional prevalence patterns
are therefore examined by separating out salmon production
sites into regions based on a United Kingdom ordnance survey
100-km2 grid. The regions identified are Shetland, Orkney, the
Outer Hebrides, and mainland Scotland. Mainland Scotland
was divided into northern and southern regions by using the
800-km north line of the United Kingdom ordnance survey’s
national grid system (Figure 1). The interannual changes in
IPNV prevalence have been examined at salmon production
sites within the regions identified above. 
Multilevel Model
Both space and time play roles in determining variance in
the observations. Simple multilevel models of the variance in
the observations allow determination of the relative contribu-
tions of these components. These models, based on normal or
binomial assumptions, were constructed by using the package
MLwiN (21). The model was constructed with binomial vari-
ance distributed according to a logistic function IPNV = [1 +
exp(–β)]–1. This model determined a mean β = –1.138
(±0.517), which gave a mean prevalence of 0.242 (24%). The
logistic function was used because it varies from 0 to 1 and
therefore covers the range of situations when IPNV is absent to
situations when it is present in all samples within a group. The
model was then used to determine the contributions of the dif-
ferent levels in the model to the variance about this mean.
The highest level of the model is the split between saltwa-
ter and freshwater environments. These salmon production
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Figure 1. Salmon production regions in Scotland, including the city of
Aberdeen, the site of the Fisheries Research Services Marine
Laboratory, where fish health inspectors and virologists are based.sites are fundamentally different in nature (3), with different
age classes of fish and routes of infection. Inclusion does add
uncertainty to the model’s output because environment has
only two classes. However, because saltwater and freshwater
sites are related at other levels in different ways, this split in
variance is explicitly modeled, rather than added as a fixed
effect. The second level is the region; at this level, different cli-
mates, environments, and local organizations (e.g., the Orkney
Fish Farmers Association) exist. The third level at which vari-
ance is resolved is that of year: because IPNV’s prevalence is
increasing, prevalence changes over time. Seasonal data are
also included because most IPNV cases occur in summer.
Seasonal effect was analyzed by using three seasons of 4
months’ duration (January–April, May–August, and
September–December) because individual months in winter are
often poorly sampled. 
Results 
Mean IPNV prevalence was determined by region, and a χ
2
test of deviation from the overall Scottish mean was conducted
(Table 1). High IPNV levels stood out in Shetland for both
freshwater and seawater sites. Northern mainland Scotland and
the Outer Hebrides showed a particularly low relative preva-
lence of IPNV in the marine sites and marginally significant
low prevalence in freshwater. Orkney also had a low preva-
lence of IPNV in freshwater; however, because we obtained
fewer data from Orkney, this finding was not significant. 
In marine sites, IPNV prevalence showed different tempo-
ral patterns in different regions (Figure 2). In most areas, IPNV
prevalence appeared to have increased from 1996 to 2001 at
approximately 10% per year (Table 2); the trends in these
regions were not significantly different from each other or from
the national mean. Analysis methods changed slightly in 2001;
however, the trend of increasing prevalence was apparent
throughout the entire 1996–2001 period. In southern mainland
Scotland, IPNV prevalence was not statistically significant. If
anything, it declined, although variation occurred from year to
year. Linear increase in IPNV prevalence in Shetland became
difficult to sustain once prevalence exceeded 80% in 1999, so
the increase reached a saturation point (Figure 2). 
In freshwater production sites, interannual variation in
IPNV prevalence increased approximately 2% to 3% per year
(Figure 3, Table 2). However, in Shetland, the increase was
faster at 6.5% year, which is significantly different from other
regressions at 90% confidence. The analysis used has not
changed for freshwater since 1993. In northern Scotland, no
significant increase has occurred, although since 1999, preva-
lence has increased. As noted earlier, prevalence of IPNV in
Shetland in freshwater is higher than in other areas and is
increasing more rapidly.
Differences between regions have decreased in recent years
in spite of increasing prevalence (Figure 4). The regions are
becoming less distinct with respect to IPNV prevalence as the
IPNV-positive regions converge.
The multilevel model has been used to determine how much
different components contribute to the variation in model
results from the overall mean of 24% (Table 3). The contribu-
tion is distributed, as expected from the observations described
earlier. Most variance is accounted for at level 2, between
regions. A substantial amount of variance is at the top level
between saltwater and freshwater environments, but, because
only two categories exist, the degree of this variance is uncer-
tain. Since slightly more sensitive methods were used to sam-
ple IPNV in freshwater than in saltwater, this difference may be
underestimated. A similar amount of  variance is accounted for
at the interannual level but with less uncertainty. Very little
variation is due to season. 
Discussion
Our analysis systematically shows that variation exists in
the distribution of IPNV in Scotland and allows a detailed pic-
ture of changes in distribution to be derived. The emergence of
IPNV has been documented, with IPNV prevalence increasing
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Table 1. Mean prevalence of infectious pancreatic necrosis virus by 
region for all 1996–2001 data, and χ
2 probability that prevalence is 
significantly different from the all-Scotland mean  
Saltwater  Freshwater 
Region  % Prevalence  χ
2 p  % Prevalence  χ
2p 
All Scotland  49.6  N/A  10.6  N/A 
North  41.1  0.001  5.5  0.1 
South  55.5  –  11.1  – 
Shetland  77.0  0.001  35.3  0.001 
Orkney  48.5  –  6.7  – 
Outer Hebrides  31.3  0.001  6.7  0.1 
Figure 2. Prevalence of infectious pancreatic necrosis virus (IPNV) in
Scottish marine salmon production sites by region and year. The
regions are northern mainland Scotland, southern mainland Scotland,
Shetland, Orkney, and the Outer Hebrides. Bars show 95% confidence
intervals.from very low levels to high levels, even to near ubiquity in
Shetland salmon farms. IPNV prevalence has typically
increased annually by 10% in saltwater and by 2% to 3% in
freshwater. In freshwater in Shetland, the annual increase was
6.5%. 
In spite of IPNV’s emergence in most of Scotland, the
virus’s prevalence did not change significantly in southern
areas; if anything, it declined. The reasons for this are unclear,
but the pattern suggests that controlling the emergence of IPNV
may be possible. In Sweden, IPNV is controlled by culling, and
the virus is officially absent from that country in spite of very
high levels in neighboring Norway (11). Notably, in 1999 or
2000 in many areas of Scotland, marine IPNV prevalence
declined, or at least increased less rapidly. This decline fol-
lowed a period of fallowing, which in turn followed widespread
culling to control the outbreak of infectious salmon anemia of
1998–99 (22,4). 
Multilevel modeling shows that the regional pattern domi-
nates the structure of variation in IPNV’s prevalence in salmon
farms, overshadowing even the difference between marine and
freshwater sites, although this could be slightly underestimated.
The strength of this regional pattern is due to the extremely
high prevalence of IPNV in Shetland and its low prevalence in
the Outer Hebrides in both freshwater and saltwater sites.
The regional variation is in decline for marine salmon
farms, however. As IPNV approaches ubiquity in Shetland, the
virus has reached the saturation point; in many other areas, the
increase remains rapid. In the Outer Hebrides, where preva-
lence was lowest, the increase has been the most rapid. As a
result, IPNV prevalence levels are converging, and the standard
deviation among regional means has declined. As the regions
have become increasingly similar, regional differentiation in
control policy becomes less useful.
Our analysis is not intended to describe the absolute preva-
lence of IPNV in Scotland. Detection limits (9,10) and, on
occasion, small numbers of fish (19) may mean that infection
may not always be detected at an infected site; thus, the true
prevalence of IPNV within samples is probably higher than
reported. Uncertainty in test results is also a fundamental limi-
tation (10) and would apply to the results of a survey specifi-
cally designed to determine viral prevalence as much as it
applies to these monitoring data. Sample site selection is not
random but is based on the need to monitor for IPNV, which
may also lead to biases. However, with a centralized organiza-
tion that collects data by standardized methods, trends and
regional variation may be analyzed in relative terms. 
Improved analysis methods may have contributed to
increases in reported IPNV prevalence in marine water in 2001;
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Table 2. Trends in annual average prevalence of infectious 
pancreatic necrosis virus for all Scotland and by regions with 
regression 90% confidence intervals, probability, and r
2a 
Region  % Annual increase  90% CI  p  r
2 
Marine sites         
All Scotland  6.2  ±3.1  0.012  0.82 
South Mainland  -3.4  ±6.2  0.306  0.26 
North Mainland  8.7  ±5.4  0.026  0.75 
Shetland  7.4  ±3.7  0.014  0.82 
Orkney  11.5  ±3.7  0.003  0.91 
Outer Hebrides  10.6  ±7.1  0.013  0.71 
Freshwater Sites         
All Scotland  2.0  ±1.5  0.051  0.66 
South Mainland  1.9  ±1.3  0.039  0.69 
North Mainland  0.4  ±1.9  0.663  0.05 
Shetland  6.5  ±3.9  0.026  0.75 
Orkney  2.4  ±2.3  0.097  0.54 
Outer Hebrides  3.0  ±2.2  0.041  0.69 
aIPNV, infectious pancreatic necrosis virus; CI, confidence intervals; p, probability; r
2, 
coefficient of determination for bivariate analysis 
 
Figure 3. Prevalence of infectious pancreatic necrosis virus (IPNV) in
Scottish freshwater salmon production sites by region and year. The
regions are northern mainland Scotland, southern mainland Scotland,
Shetland, Orkney, and the Outer Hebrides. Bars show 95% confidence
intervals.
Figure 4. Mean of regional annual mean prevalence of infectious pan-
creatic necrosis virus in marine salmon farms (thin dashed line) and
standard deviation of regional annual means (thick solid line), by year.
Individual marine regional annual means are shown by circles (where
two circles overlay, a large square is added). Standard deviation has
fallen at an increasing rate, in spite of increasing mean regional preva-
lence.Emerging Infectious Diseases • Vol. 9, No. 4, April 2003 459
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however, this increase continues a trend and reflects an
increase in clinical IPN cases (11,15). Increased experience per
se is unlikely to be a factor in increased detection during the
study period since the FRS Marine Laboratory has been sam-
pling for IPNV since the 1970s (18) and has contributed to the
development of standard tests (9). Moreover, prevalence shows
different temporal patterns in different areas, in spite of central-
ly controlled methods and personnel. These increases therefore
cannot be explained in terms of improvements in methods, nor
can differences in methodology be used to explain regional dif-
ferences in prevalence. In addition, sampling methods used in
freshwater may be slightly more sensitive than those used for
marine sites, which could mean the difference in prevalence
between fresh and marine waters is even larger than reported
here. Because IPNV has a wide variety of host species (7,13),
persistent carriers among recovered hosts (23), and the ability
to be carried by piscivorous bird vectors (24), the virus is diffi-
cult to eradicate, once established. Given IPNV prevalence
increases of approximately 10% per year, effective control
would have to be reestablished very soon if IPNV is not to
become as ubiquitous in most areas as it is in Shetland. Owing
to limitations in detection methods, IPNV prevalence in sam-
ples may be even higher than reported (10). IPNV prevalence
has been held steady in southern areas of Scotland, indicating
that an increase is not inevitable; Sweden has maintained
IPNV-free status. In freshwater sites in Scotland, IPNV is less
prevalent, and the prevalence is increasing at lower rates; there-
fore, control can likely be reasserted in freshwater.
IPNV is one of a series of emerging pathogens causing seri-
ous economic damage to aquaculture in Scotland (6,22) and
around the world (1,2). Although data collected from programs
to monitor these pathogens are not always statistically unbi-
ased, they form a valuable resource on emerging and estab-
lished (8) diseases. As further fish species are cultivated (e.g.,
cod Gadus morhua [3,7]), such data are required to design a
sustainable industry.
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